For questions about BMS medicines during this time please call 1-800-721-8909.

ONUREG® is indicated for continued treatment of adult patients with acute myeloid leukemia who achieved first complete remission (CR) or complete remission with incomplete blood count recovery (CRi) following intensive induction chemotherapy and are not able to complete intensive curative therapy.

Close

Resources

Resources for healthcare providers

Be sure to bookmark or return to this page to remember these helpful resources.

Resources for patients and caregivers

Be sure to bookmark or return to this page to remember these helpful resources.